Brian Johnston, PA
Medical · Paducah, KYNPI 1871668525
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,788 of the $3,987 with a category attached, or 69.9%. 26 manufacturers reported payments, led by Medtronic at 26.1% of the total. Reporting peaked in 2023 at $1,528 and has fallen 50.8% since, to $752 in 2025.
Across 156 payments — averaging $25.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Johnson & Johnson$782
- Sumitomo Pharma America, Inc.$539
- Astellas Pharma US Inc$385
- 180 Medical, Inc.$180
- Urogen Pharma, Inc.$126
- plus $934 from 20 others
What the payments were for
- Travel & lodging$1,00925%
- Food & beverage$2,78870%
- Education$1905%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 4 | $1,042 |
| Johnson & Johnson | 45 | $782 |
| Sumitomo Pharma America, Inc. | 27 | $539 |
| Astellas Pharma US Inc | 20 | $385 |
| 180 Medical, Inc. | 8 | $180 |
| Urogen Pharma, Inc. | 6 | $126 |
| Boston Scientific | 7 | $124 |
| Pfizer | 6 | $108 |
| AbbVie | 4 | $76 |
| Innovation Technologies Inc | 1 | $73 |
| C. R. Bard, Inc. & Subsidiaries | 3 | $72 |
| Sun Pharmaceutical Industries Inc. | 3 | $66 |
| Tolmar Pharmaceuticals, Inc. | 3 | $58 |
| ABC Home Medical Supply, Inc. | 3 | $51 |
| Coloplast | 2 | $41 |
| KARL Storz Endoscopy-america | 1 | $37 |
| Procept Biorobotics Corporation | 2 | $33 |
| Photocure Inc | 2 | $33 |
| Urovant Sciences Inc | 2 | $31 |
| Axonics, Inc. | 1 | $24 |
| Merck | 1 | $23 |
| Bayer | 1 | $18 |
| Progenics Pharmaceuticals, Inc. | 1 | $18 |
| Tolmar, Inc. | 1 | $16 |
| Endo Pharmaceuticals Inc. | 1 | $16 |
| Immunitybio, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,987 in reported general payments places this provider in the 80th percentile of 222 medical providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 291 | $200,899 |
| GemtesaVibegron | 252 | $168,196 |
| Mirabegron ErMirabegron | 38 | $25,688 |
| Tamsulosin Hcl | 946 | $12,494 |
| PremarinEstrogens, Conjugated | 17 | $7,257 |
| Solifenacin Succinate | 81 | $5,739 |
| Trimethoprim | 71 | $5,329 |
| Finasteride | 272 | $2,730 |
| Potassium Citrate ErPotassium Citrate | 12 | $2,618 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 86 | $1,842 |
| NitrofurantoinNitrofurantoin Macrocrystal | 89 | $1,830 |
| Bethanechol Chloride | 20 | $1,648 |
| Trospium Chloride | 21 | $1,362 |
| Estradiol | 18 | $1,198 |
| Cefdinir | 52 | $838 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $385 | $200,899291 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $539 | $168,196252 claims |
| PfizerPremarin | $108 | $7,25717 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 222 medical providers in Kentucky.
Other medical in Paducah
- Mikal BaileyPaducah$84K
- Jessica FrizzellPaducah$10K
- Rachel CrowleyPaducah$8K
- Emily LopezPaducah$6K
- Brandon MoreheadPaducah$6K
- Scott HarpPaducah$6K
- Lacy BoydPaducah$4K
- Dawn HollandPaducah$3K
- Kyle HeraldBowling Green$65K
- Chasity HesterLexington$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.